The 89-kDa cell surface glycoprotein, P3.58, is detectable on advanced human melanomas in situ but not on benign melanocytes or early melanomas. cDNA cloning of P3.58 from melanoma cells was accomplished by screening a A zap expression vector library with monoclonal antibodies produced against the denatured antigen. Nucleotide sequencing of the clones revealed that P3.58 is identical to the intercellularadhesion molecule 1. No qualitative differences in P3.58 mRNA species could be seen between melanoma cells and hematopoietic cells and no differences in gene organization were observed between peripheral blood leukocytes and melanoma cells. Inspection of the deduced amino acid sequence of P3.58 indicated the presence of the consensus sequence characteristic for complement-binding proteins. The acquisition of this cell-adhesion molecule during the process of tumor progression is speculated to contribute to the development of metastasis in melanoma.
Immunohistochemical analysis of in situ phenotypic changes correlating with tumor progression in human cutaneous melanoma has led to the identification of molecules potentially involved in metastasis (1, 2) . One of these is the melanoma-associated antigen P3.58, an 89-kDa cell surface glycoprotein (3) , that is not detectable on quiescent melanocytes and is only sporadically found on proliferative benign melanocytic lesions (i.e., nevi). On melanomas the frequency with which this antigen is found increases with increasing tumor thickness (2) . Among normal tissues, P3.58 expression is limited to vascular endothelia, lymphoid follicle germinal centers, and tissue macrophages (4) . It is expressed by adherent monocytes and Epstein-Barr virus-transformed B-cell lines and can be modulated in vitro by interferon y and tumor necrosis factor type a (2, 4) .
Here we report the isolation of cDNA clones encoding the P3.58 antigen from melanoma cells. Nucleotide sequencing of these clones revealed that the P3.58 antigen is identical to the intercellular adhesion molecule 1 (ICAM-1), a cell adhesion molecule (CAM) mediating leukocyte adhesion through the lymphocyte function-associated molecule 1 (LFA-1) (5). CAMs mediating homotypic and heterotypic cell contacts are essential for the assembly and maintenance of the cellular architecture of complex tissues (6, 7) . The perturbations of normal cell interactions that characterize invasive and metastatic malignant cells might, therefore, be expected to reflect changes in CAM function. Although the highly malignant Wilms tumor was shown (8) to express a low-adhesive form of the neural adhesion molecule, a direct association between the expression of CAMs and behavior of tumors in vivo has not been observed. We speculate that the de novo expression of ICAM-1 by melanomas leads to heterotypic adhesion between melanoma cells and LFA-1-bearing leukocytes and thereby contributes to dissemination of the cells from the primary tumor.
MATERIALS AND METHODS
Immunohistochemistry. Tissues were quickly frozen in liquid nitrogen and stored at -70'C. Indirect immunoperoxidase staining was performed as described (2) by using 3-amino-9-ethylcarbazole (0.25 mg/ml in 0. Antibodies and Cells. Antibodies P3.58a and p3.58b were isolated after immunization with fresh melanoma tumor material and were selected for their discrimination between malignant melanoma and benign nevi on frozen tissue sections (3, 4) . Eleven monoclonal antibodies were produced against denatured P3.58 antigen isolated by affinity chromatography from 3 x 109 interferon-y-stimulated Mel JuSo cells. The antibodies also reacted with native P3.58 antigen and precipitated only this molecule from radiolabeled melanoma cells.
The L89 transfectant cell line was obtained after cotransfection of murine Ltk-cells with Mel JuSo DNA and the thymidine kinase gene (ptk-5) as described (4) . Human cell lines were established in our laboratory, or obtained from the American Type Culture Collection, and were cultured in RPMI 1640 containing 10% (vol/vol) fetal calf serum, 1 mM sodium pyruvate, and antibiotics. Interferon-stimulated cells were cultured for 48 hr in recombinant interferon y at 100 units/ml (Bioferon, Laupheim, F.R.G.). The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Progression. The vertical thickness of primary tumors is a measure of progression in melanoma and is directly correlated with the probability of metastatic disease (11) . The frequency of P3.58 expression on malignant melanomas in situ increases with increasing tumor thickness (2) . The finding that P3.58 is a leukocyte activation antigen primarily expressed on monocytes and macrophages (4) prompted an examination of additional tumors and staining of serial sections with an antibody specific for CD45 to identify infiltrating leukocytes. These results confirmed our initial observations but revealed a nonlinear correlation with tumor thickness (Fig. 1) ICt-1 (341-404) slight increase in incidence with increasing tumor thickness. The association between P3.58 expression and tumor thickness suggests that the appearance of this molecule reflects a change in the tumor cells that may contribute to the development of metastatic capacity. The abrupt increase in incidence of P3.58 expression on tumors of 1 mm is consistent with the hypothesis, derived primarily from experimentally induced tumors, that the progression of malignant tumors occurs by a series of discontinuous steps, each of which is delineated by the sudden appearance of new characteristics (12) .
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Identification of cDNA Clones Encoding P3.58. Approximately 360,000 phage from a melanoma cDNA A zap expression library were screened with a panel of four monoclonal antibodies produced against denatured P3.58 antigen. A single clone, A89-1 was isolated. This clone contained a 2.7-kilobase (kb) insert encoding a product reactive with six antibodies. Two additional clones (A89-48 of 1 kb and A89-49 of 1.6 kb) were isolated from a Agtll cDNA melanoma library by hybridization with A89-1. To confirm that A89-1 contained P3.58 cDNA, it was hybridized to DNA and RNA isolated from L89, a P3.58-expressing L cell obtained after transfection with DNA derived from the melanoma cell line Mel JuSo (5). Identical mRNA species and genomic fragments were observed in L89 and melanoma cells ( Fig. 2A, lanes 1 and 2, and B, lanes 5-8 and 13-16). No hybridization was seen with RNA or DNA isolated from the untransfected Ltk-cells ( Fig. 2A, lane 3, and B, lanes 9-12) . Furthermore, in A375 melanoma cells mRNA hybridizing with A89-1 was detected only after interferon-y stimulation ( Fig. 2A, lanes 4 and 5) , which is also required to obtain expression of the P3.58 antigen (2) .
Clones A89-1, A89-48, and A89-49 were subcloned into the vector pUC18 and sequenced by using the dideoxy chaintermination method (9) . The sequence obtained was identical to that of ICAM-1 isolated from myeloid and endothelial cells (refs. 13 and 14; data not shown).
Characterization of P3.58 mRNA and Genomic Organization. Comparison of melanoma and hematopoietic cells revealed no qualitative differences in P3.58/ICAM-1 mRNA species or gene organization. Melanoma, monoblast, and B-cell lines expressed two species of mRNA (3.4 and 2.6 kb) hybridizing with A89-1 ( Fig. 2A, lanes 1 and 6-8 ). Restriction analyses of genomic DNA isolated from melanoma cells and peripheral blood mononuclear cells showed one major band, consistent with a single-copy gene (Fig. 2B, lanes 1-4 and 13 (15) . C3-and C4-binding proteins are characterized by a consensus sequence of -60 amino acids containing a framework of highly conserved residues (16, 17) . Inspection of the deduced amino acid sequence revealed the presence of the C3/C4-binding protein consensus sequence between residues 341 and 404 (Fig. 3) . This region, which spans the junction between the putative fourth and fifth immunoglobulin-like domains of ICAM-1, lacks several of their typical features (14) and thus might form the loop predicted for the C3/C4-binding proteins (17) . The presence of this consensus sequence together with the antibody-blocking studies suggest that ICAM-1 may be involved in C3b binding. Since C3b-binding proteins generally act to accelerate the dissociation of active complement complexes (16), the expression of P3.58/ ICAM-1 may help the tumor escape immune destruction, providing an important property needed for successful metastasis. In support of this proposal is the observation that melanoma cell lines have been shown to escape complementdependent cytotoxicity in vitro through the rapid inactivation of cell-bound C3b (22) .
The expression of ICAM-1 may contribute to the metastatic capability of melanoma cells through several mechanisms. ICAM-1 has been shown to directly bind to LFA-1 (5), an adhesion glycoprotein broadly expressed on cells of the hematopoietic lineage (23, 24) . Since LFA-1-negative melanoma cells nevertheless participate in LFA-1-dependent monocyte adhesion (25) , the melanoma P3.58/ICAM-1 molecule may also function as a LFA-1 ligand. Through this interaction, melanoma cells could establish heterotypic cell contacts with leukocytes present in the tumor infiltrate. This might lead to a reduction in homotypic adhesion between melanoma cells while enhancing tumor cell adhesion to migratory and invasive leukocytes enabling individual cells to dissociate from the primary tumor.
CAMs play an important role in organogenesis and tissue regeneration, where their expression is regulated by microenvironmental signals (6) . In this context it is of interest that P3.58 expression in primary melanomas correlates with the local presence of leukocytes containing its inducer, interferon y (26) . Such observations suggest that the role of the mononuclear cell infiltrate in melanomas may be two sided. Infiltrating leukocytes have been shown to include cells capable of specifically killing the tumor cells in vitro (27) . However, by regulating gene expression in the tumor cells, the mononuclear cell infiltrate may also play a direct role in the acquisition of properties that contribute to progression of the tumor toward metastatic disease.
